Portal de Periódicos da CAPES

Rheumatoid Arthritis in the Elderly

1991; Wiley; Volume: 39; Issue: 3 Linguagem: Inglês

10.1111/j.1532-5415.1991.tb01653.x

1532-5415

Gideon Nesher, Terry L. Moore, Jack Zuckner,

Rheumatoid Arthritis Research and Therapies

Journal of the American Geriatrics SocietyVolume 39, Issue 3 p. 284-294 Progress in Geriatrics Rheumatoid Arthritis in the Elderly Gideon Nesher MD, Gideon Nesher MDSearch for more papers by this authorTerry L. Moore MD, Corresponding Author Terry L. Moore MDAddress correspondence to Terry L. Moore, MD, Professor of Internal Medicine and Pediatrics-Adolescent Medicine, Director, Division of Rheumatology, St. Louis University School of Medicine, 1402 South Grand Boulevard, R215 Doisy Hall, St. Louis, MO 63104.Search for more papers by this authorJack Zuckner MD, Jack Zuckner MDSearch for more papers by this author Gideon Nesher MD, Gideon Nesher MDSearch for more papers by this authorTerry L. Moore MD, Corresponding Author Terry L. Moore MDAddress correspondence to Terry L. Moore, MD, Professor of Internal Medicine and Pediatrics-Adolescent Medicine, Director, Division of Rheumatology, St. Louis University School of Medicine, 1402 South Grand Boulevard, R215 Doisy Hall, St. Louis, MO 63104.Search for more papers by this authorJack Zuckner MD, Jack Zuckner MDSearch for more papers by this author First published: March 1991 https://doi.org/10.1111/j.1532-5415.1991.tb01653.xCitations: 21 From the Department of Internal Medicine, Division of Rheumatology, St. Louis University School of Medicine, St. Louis, Missouri. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Mitchell D. Epidemiology. In: PD Utsinger, NJ Zvaifler, GE Ehrlich, eds. Rheumatoid Arthritis. Philadelphia: JB Lippincott, 1985, p 133. 2Brown JW, Sones DA. The onset of rheumatoid arthritis in the aged. J Am Geriatr Soc 1967; 15: 873. 3Cecil RL, Kammerer WH. Rheumatoid arthritis in the aged. Am J Med 1951; 10: 439. 4Dordick JR. Rheumatoid arthritis in elderly. J Am Geriatr Soc 1956; 4: 588. 5Ehrlich GE, Katz WA, Cohen SH. Rheumatoid arthritis in the aged. Geriatrics 1970; 25: 103. 6Harris ED. The clinical features of rheumatoid arthritis, In: WN Kelley, ED Harris, S Ruddy, CB Sledge, eds. Textbook of Rheumatology. Philadelphia: WB Saunders, 1989, p 944. 7Robinson HS. Multidisciplinary ambulatory care for the elderly arthritis patient, In: RW Moskowitz, MR Haug, eds. Arthritis and the Elderly. New York: Springer, 1986, p 146. 8Bergstrom G, Bjelle A, Sorensen LB, et al. Prevalence of rheumatoid arthritis, osteoarthritis, chondrocalcinosis, and gouty arthritis at age 79. J Rheumatol 1986; 13: 527. 9Zvaifler NJ. New perspectives on the pathogenesis of rheumatoid arthritis. Am J Med 1988; 85 (Supple 4A): 12. 10Condemi JJ. The autoimmune diseases. JAMA 1987; 258: 2920. 11Dorner RW, Moore TL. Rheumatoid factors. Clin Chim Acta 1987; 167: 1. 12Moore TL, Dorner RW, Osborn TG, Zuckner J. Hidden 19S IgM rheumatoid factors. Semin Arthritis Rheum 1988; 18: 72. 13Firestein GS, Tsai V, Zvaifler NJ. Cellular immunity in the joints of patients with rheumatoid arthritis and other forms of chronic synovitis. Rheum Dis Clin North Am 1987; 13: 191. 14Schumacher HR, Kitridou RC. Synovitis of recent onset. Arthritis Rheum 1972; 15: 465. 15van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975; 293: 517. 16Pitzalis C, Kingsley G, Haskard D, et al. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: Evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988; 18: 1397. 17Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277. 18Knottinen YT, Reitamo S, Ranki A, et al. Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum 1983; 24: 71. 19Fox RI, Fong S, Sabharwal U, et al. Synovial fluid lymphocytes differ for peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 1982; 128: 352. 20Robbins DL, Kenny TP, Coloma MJ, et al. Serologic and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells. Arthritis Rheum 1990; 33: 1188. 21Venables PJW. Infection and rheumatoid arthritis. Curr Opin Rheumatol 1989; 1: 15. 22Phillips PE. Evidence implicating infectious agents in rheumatoid arthritis and juvenile rheumatoid arthritis. Clin Exp Rheumatol 1988; 6: 87. 23Alspaugh MA, Henle G, Lennette ET, et al. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1981: 67: 1134. 24Roudier J, Pedersen J, Rhodes GH, et al. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-DR4, DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA 1989; 86: 5104. 25Naides SJ, Scharosch LL, Feto F, et al. Rheumaotologic manifestations of human parvovirus B19 infections in adults. Arthritis Rheum 1990; 33: 1297. 26Stuart JM, Townes AS, Kang AH. Collagen autoimmune arthritis. Ann Rev Immunol 1984; 2: 199. 27Choi EK, Gatenby PA, McGill MW, et al. Autoantibodies to type II collagen occurrence in rheumatoid arthritis, etc. Ann Rheum Dis 1988; 47: 313. 28Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452. 29Parekh RB, Isenberg DA, Ansell BM, et al. Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile-onset rheumatoid arthritis and relation to disease activity. Lancet 1988; 1: 966. 30Carson DA, Chen PP, Kipps TJ, et al. Idiotypic and genetic studies of human rheumatoid factors. Arthritis Rheum 1987; 30: 1321. 31Silverman GJ, Goldfien RD, Chen P, et al. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors: Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest 1988; 82: 469. 32Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305. 33Terkeltaub R, Esdaile J, Decasry F, et al. A clinical study of older age rheumatoid arthritits with comparison to a younger onset group. J Rheumatol 1983; 10: 419. 34Corrigan AB, Robinson RG, Terenty JR, et al. Benign rheumatoid arthritis of the aged. Br Med J 1979; 1: 444. 35Adler E. Rheumatoid arthritis in old age. Isr J Med Sci 1966; 2: 607. 36Deal CL, Meenan RF, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 1985; 28: 987. 37Fleming A, Crown JM, Corbett M. Early rheumatoid disease. 2. Patterns of joint involvement. Ann Rheum Dis 1976; 35: 361. 38Bland J, Eddy W. Hemiplegia and rheumatoid hemiarthritis. Arthritis Rheum 1968; 11: 72. 39Masi JT, Feigenbaum SL, Kaplan SB. Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983; (Suppl 1): 17. 40Zuckner J. The progression of rheumatoid arthritis in relationship to prognostic factors. In: PD Utsinger, NJ Zvaifler, GE Ehrlich, eds. Rheumatoid Arthritis, Philadelphia: JB Lippincott, 1985, p 309. 41Van der Heijde DMFM, Van Riel PLCM, Van Rijswijk MH, et al. Influence of prognostic features on the final outcome in rheumatoid arthritits. A review of the literature. Semin Arthritis Rheum 1988; 17: 284. 42Schnell A. The clinical features of rheumatic infection in the old. Acta Med Scand 1941; 106: 345. 43Mathews JA. Atlanta axial subluxation in rheumatoid arthritis: A five-year follow-up study. Ann Rheum Dis 1974; 33: 526. 44Gardner GC, Weisman MH. Pyarthrosis in patients with rheumatoid arthritis: A report of 13 cases and a review of the literature from the past 40 years. Am J Med 1990; 88: 503. 45Krane SM, Simon LS. Rheumatoid arthritis: Clinical features and pathogenetic mechanisms. Med Clin North Am 1986; 70: 263. 46Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: Survival and associated risk factors. Medicine 1986; 65: 365. 47Bernhard G. Extra-articular rheumatoid arthritis: Clinical features and treatment overview. In: PD Utsinger, NJ Zvaifler, GE Ehrlich, eds. Rheumatoid arthritis, Philadelphia: JB Lippincott, 1985, p 331. 48Hara KS, Ballard DJ, Ilstrup DM, et al. Rheumatoid pericarditis: Clinical features and survival. Medicine 1990; 69: 81. 49Baer NA, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritits: A clinical and laboratory analysis. Semin Arthritis Rheum 1990; 19: 209. 50Vreugdenhil G, Wognum AW, van Eijk HG, Swaak AJG. Anemia in rheumatoid arthritis: The role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 1990; 49: 93. 51Goldberg J, Pinals RS. Felty syndrome. Semin Arthritis Rheum 1980; 10: 52. 52Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: A case-matched study of clinical manifestations and outcome, serologic features, and immunologic associations. Medicine 1990; 69: 69. 53Andonopoulos PA, Drosos AA, Skopouli FN, et al. Secondary Sjogren's syndrome in rheumatoid arthritis. J Rheumatol 1987; 14: 1098. 54Sambrook PN, Eisman JA, Champion GD, et al. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987; 30: 721. 55Del Puente A, Knowler WC, Pettitt DJ, et al. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988; 31: 1239. 56Moore TL, Dorner RW, Zuckner J. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis. J Lab Clin Med 1986; 107: 465. 57Heimer R, Levin FM, Rudd E. Globulins resembling rheumatoid factor in serum of the aged. Am J Med 1963; 35: 175. 58Waller M, Toone BC, Vaughan JH. Study of the rheumatoid factor in a normal population. Arthritis Rheum 1964; 7: 513. 59Shearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986; 13: 297. 60Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315. 61Healey LA, Sheets PK. The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1988; 15: 750. 62Lawry GV, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: A prospective, comparative analysis of clinical features. Medicine 1988; 67: 335. 63Caldwell DS, McCallum RM. Rheumatologic manifestations of cancer. Med Clin North Am 1986; 70: 385. 64Sheon RP, Kirsner AB, Tangsintanapas P, et al: Malignancy in rheumatic disease: Interrelationships. J Am Ger Soc 1977; 25: 20. 65Schur PH. Clinical features of SLE, In: WN Kelley, ED Harris, S Ruddy, CB Sledge, eds. Textbook of Rheumatology. Philadelphia: WB Saunders Company, 1989, p 1101. 66Wilson HA, Hamilton ME, Spyker DA, et al. Age influences the clinical and serological expression of systemic lupus erythematosus. Arthritis Rheum 1981; 24: 1230. 67Moutsopoulos HM, Webber BL, Vlogopoulos TP, et al. Differences in the clinical manifestations of Sicca syndrome in the presence and absence of rheumatoid arthritits. Am J Med 1979; 66: 733. 68Goldenberg DL. Fibromyalgia syndrome (fibrositis). Mediguide Inflam Dis 1989; 7: 1. 69Ditunno J, Ehrlich GE. Care and training of elderly patients with rheumatoid arthritis. Geriatrics 1970; 25: 164. 70Morgan J, Furst DE. Implications of drug therapy in the elderly. Clin Rheumat Dis 1986; 12: 227. 71Abramson SB, Weissmann G. The mechanism of action of non steroidal anti-inflammatory drugs. Arthritis Rheum 1989; 32: 1. 72Kimberly RP, Plotz PH. Salicylates including aspirin and sulfas alazine. In: WN Kelley, ED Harris, S Ruddy, CB Sledge, eds. Textbook of Rheumatology. Philadelphia: WB Saunders, 1989, p 739. 73Paulus HE. Non-steroidal anti-inflammatory drugs. In: WN Kelly, ED Harris, S Ruddy, CB Sledge, eds. Textbook of Rheumatology. Philadelphia: WB Saunders Company, 1989, p 765. 74Schlegel SI, Paulus HE. Non-steroidal and analgesic therapy in the elderly. Clin Rheum Dis 1986; 12: 245. 75Nesher G, Zimran A, Hershko C. Reduced incidence of hyper kalemia and azotemia in patients receiving sulindac compared with indomethacin. Nephron 1988; 48: 291. 76Lequesne M. Alternative therapies for high-risk elderly rheumatic patients. Gerontology 1988; 34 (suppl): 33. 77Roth S, Bennett R, Caldron P, et al. Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): An endoscopic study. Semin Arthritis Rheum 1990; 19 (suppl 2): 11. 78Lanza FL, Aspinol RL, Swabb EA, et al. Double blind placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolectin-induced mucosal injury to the stomach and duodenum. Gastroenterol 1988; 95: 289. 79Caldwell JR, Roth SH, We WC, et al. Sucralfate treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med 1987; 83: 74. 80Roth S, Agrawal N, Mahowald M, et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989; 149: 775. 81Wilske KR, Healey LA. Remodeling the pyramid - a concept whose time has come. J Rheumatol 1989; 16: 565. 82Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome?. J Rheumatol 1989; 16: 1. 83O'Callaghan JW, Brooks PM. Disease modifying agents and immunosuppressive drugs in the elderly. Clin Rheumatol Dis 1986; 12: 275. 84Kean WF, Bellamy N, Brooks PM. Gold therapy in the elderly rheumatoid arthritis patient. Arthritis Rheum 1983; 26: 705. 85Kean WF, Anastassiades TP, Dwosh IL, et al. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. J Am Geriatr Soc 1982; 30: 94. 86McCarty DJ. Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. Arthritis Rheum 1972; 15: 157. 87Sledge CB. Introduction to surgical management. In WN Kelly, ED Harris, S Ruddy, CB Sledge, eds. Textbook of Rheumatology. Philadelphia: WB Saunders Company, 1989, p 1927. 88Sledge CB, Liang MH, Cullen KE. Therapeutic problems unique to the elderly in surgery and joint replacement. In RW Moskowitz, MR Haug, eds. Arthritis and the Elderly. New York: Springer, 1986, p 104. 89Paulus HE. Current controversies in rheumatology: The use of combinations of disease modifying anti-rheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990; 33: 113. 90Klippel JH, Strober S, Wofsy D. New therapies for the rheumatic diseases. Bull Rheum Dis 1989; 38(4): 1. Citing Literature Volume39, Issue3March 1991Pages 284-294 ReferencesRelatedInformation